AFP and hepatocellular carcinoma: In previous studies, the sensitivity of PIVKA-II in the diagnosis of HCC was 51.0–77%, the specificity was 67.8–91.2%, and the AUROC was 0.701–0.854, all of which were higher than the sensitivity, specificity, and the AUROC of AFP [16, 26].